ICAM-1 (LB-2) Antibody sc-18908 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemICAM-1 (LB-2) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-18908
Antibody TypePrimary Antibodies
NCBI Gene AliasesBB2, CD54, P3.58
CloneLB-2
ApplicationsWB, IP, IF, FCM
Quantity200 µg/ml
Reactivityhuman
ClonalityMonoclonal
FormatPurified
Conjugate/TagUnconjugated
Hostmouse
NCBI Full Gene Nameintercellular adhesion molecule 1
TargetICAM-1
IsotypeIgG2b

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Creation of an Anti-Inflammatory, Leptin-Dependent Anti-Obesity Celastrol Mimic with Better DruggabilityFrontiers in pharmacologyJanuary 1, 2021Zhou B, Yuan Y, Shi L, Hu S, Wang D, Yang Y, Pan Y, Kong D, Shikov AN, Duez P, et al.

(2) Engineering a yeast double-molecule carrier for drug screeningArtificial cells, nanomedicine, and biotechnologyJanuary 1, 2018Zhang Q, Hu S, Wang K, Cui M, Li X, Wang M, Hu X.

(3) Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis opticaScience translational medicineJuly 5, 2017Shimizu F, Schaller KL, Owens GP, Cotleur AC, Kellner D, Takeshita Y, Obermeier B, Kryzer TJ, Sano Y, Kanda T, et al.(mAb) (1:400; Cell Signaling Technology, #8242), ICAM-1 mouse mAb (1:400; Santa Cruz Biotechnology, sc-18908), claudin-5 rabbit mAb (1:1000; Abcam, ab53765) or mouse mAb (1:50; Life Technologies, #187364), GRP78

(4) Senescence-associated release of transmembrane proteins involves proteolytic processing by ADAM17 and microvesicle sheddingFASEB journal : official publication of the Federation of American Societies for Experimental BiologyNovember 1, 2014Effenberger T, von der Heyde J, Bartsch K, Garbers C, Schulze-Osthoff K, Chalaris A, Murphy G, Rose-John S, Rabe B.

(5) An in vitro blood-brain barrier model combining shear stress and endothelial cell/astrocyte co-cultureJournal of neuroscience methodsJuly 30, 2014Takeshita Y, Obermeier B, Cotleur A, Sano Y, Kanda T, Ransohoff RM.(COVANCE, Madison, WI: #SM1-26R), anti-human ICAM1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA: #sc-18908) and Alexa Fluor®488 goat anti-rabbit IgG (Invitrogen, Carlsbad, CA: #A-11008) and anti-mouse IgG (Invitrogen:

(6) High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapseJournal of virologyFebruary 1, 2014Duncan CJ, Williams JP, Schiffner T, Gärtner K, Ochsenbauer C, Kappes J, Russell RA, Frater J, Sattentau QJ.

(7) α(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitroJournal of cellular physiologyDecember 1, 2012Yosef N, Ubogu EE.

(8) Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endotheliumArteriosclerosis, thrombosis, and vascular biologyMay 1, 2012Serrano D, Bhowmick T, Chadha R, Garnacho C, Muro S.

(9) Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patientsPloS oneJanuary 1, 2012Labarrere CA, Woods JR, Hardin JW, Campana GL, Ortiz MA, Jaeger BR, Baldridge LA, Pitts DE, Kirlin PC.

(10) Tunable physiologic interactions of adhesion molecules for inflamed cell-selective drug deliveryBiomaterialsMay 1, 2011Kang S, Park T, Chen X, Dickens G, Lee B, Lu K, Rakhilin N, Daniel S, Jin MM.

(11) Early prediction of cardiac allograft vasculopathy and heart transplant failureAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsMarch 1, 2011Labarrere CA, Woods JR, Hardin JW, Campana GL, Ortiz MA, Jaeger BR, Reichart B, Bonnin JM, Currin A, Cosgrove S, et al.

(12) Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammationJournal of neuroimmunologyOctober 1, 2006Ubogu EE, Callahan MK, Tucky BH, Ransohoff RM.

(13) Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteinsAmerican journal of physiology. Lung cellular and molecular physiologyMay 1, 2006Muro S, Mateescu M, Gajewski C, Robinson M, Muzykantov VR, Koval M.

(14) ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugsBloodJanuary 15, 2005Muro S, Gajewski C, Koval M, Muzykantov VR.

Be the First to Write a Review!

ICAM-1 (LB-2) Antibody

ICAM-1 (LB-2) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (14)

Reviews

ICAM-1 (LB-2) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map